List-I | List-II | ||
A | C4 Pathway | I. | \(2\text{H}_2\text{O}\rightarrow4\text{H}^++\text{O}_2=4\text{e}^-\) |
B. | Light reaction | II. | Ribulose 1,5-bisphosphate |
C. | Photorespiration | III. | -carbon molecule phosphoenol |
D. | Calvin cycle | IV. | Phosphoglycolate |
List-I (Measured values) |
List-II (Significant figures) |
||
A | \(0.001213\) | I | \(2\) |
B | \(2.1 \times 10^{16} \) | II | \(3\) |
C | \(3.70\) | III | \(1\) |
D | \(3000\) | IV | \(4\) |
1. | A-III, B-II, C-I, D-IV |
2. | A-III, B-I, CII, D-IV |
3. | A-I, B-II, C-IV, D-III |
4. | A-IV, B-I, C-II, D-III |
List-I | List-II | ||
A. | Emphysema | I. | Proliferation of fibrous tissues |
B. | Asbestosis | II. | Alveolar walls are damaged and respiratory surface is decreased |
C. | Asthma | III. | Serious lung damage |
D. | Fibrosis | IV. | Difficulty in breathing due to inflammation of bronchi and bronchioles |
List-I (Series) |
List-II (Wave number in cm-1) |
||
A. | Balmer series | I. | \( R\left(\frac{1}{1^2}-\frac{1}{n^2}\right) \) |
B. | Lyman series | II. | \( R\left(\frac{1}{4^2}-\frac{1}{n^2}\right) \) |
C. | Brackett series | III. | \( R\left(\frac{1}{5^2}-\frac{1}{n^2}\right) \) |
D. | Pfund series | IV. | \( R\left(\frac{1}{2^2}-\frac{1}{n^2}\right)\) |